FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4206347893> ?p ?o ?g. }

• W4206347893 endingPage "117822342110651" @default.
• W4206347893 startingPage "117822342110651" @default.
• W4206347893 abstract "The Cry1Ac protoxin from Bacillus thuringiensis is a systemic and mucosal adjuvant, able to confer protective immunity in different infection murine models and induce both Th1 and TCD8+ cytotoxic lymphocyte responses, which are required to induce antitumor immunity. The Cry1Ac toxin, despite having not being characterized as an adjuvant, has also proved to be immunogenic and able to activate macrophages. Here, we investigated the potential antitumor adjuvant effect conferred by the Cry1Ac protoxin and Cry1Ac toxin in a triple negative breast cancer (TNBC) murine model. First, we evaluated the ability of Cry1Ac proteins to improve dendritic cell (DC) activation and cellular response through intraperitoneal (i.p.) coadministration with the 4T1 cellular lysate. Mice coadministered with the Cry1Ac protoxin showed an increase in the number and activation of CD11c+MHCII- and CD11c+MHCII+ low in the peritoneal cavity and an increase in DC activation (CD11c+MHCII+) in the spleen. Cry1Ac protoxin increased the proliferation of TCD4+ and TCD8+ lymphocytes in the spleen and mesenteric lymph nodes (MLN), while the Cry1Ac toxin only increased the proliferation of TCD4+ and TCD8+ in the MLN. Remarkably, when tested in the in vivo TNBC mouse model, prophylactic immunizations with 4T1 lysates plus the Cry1Ac protoxin protected mice from developing tumors. The antitumor effect conferred by the Cry1Ac protoxin also increased specific cytotoxic T cell responses, and prevented the typical tumor-related decrease of T cells (TCD3+ and TCD4+) as well the increase of myeloid-derived suppressor cells (MDSC) in spleen. Also in the tumor microenvironment of mice coadministered twice with Cry1Ac protoxin immunological improvements were found such as reductions in immunosupressive populations (T regulatory lymphocytes and MDSC) along with increases in macrophages upregulating CD86. These results show a differential antitumor adjuvant capability of Cry1Ac proteins, highlighting the ability of Cry1Ac protoxin to enhance local and systemic tumor immunity in TNBC. Finally, using a therapeutic approach, we evaluated the coadministration of Cry1Ac protoxin with doxorubicin. A significant reduction in tumor volume and lung metastasis was found, with increased intratumoral levels of tumor necrosis factor-α and IL-6 with respect to the vehicle group, further supporting its antitumor applicability." @default.
• W4206347893 created "2022-01-26" @default.
• W4206347893 creator A5027007571 @default.
• W4206347893 creator A5032831685 @default.
• W4206347893 creator A5049906723 @default.
• W4206347893 creator A5067637757 @default.
• W4206347893 date "2022-01-01" @default.
• W4206347893 modified "2023-10-14" @default.
• W4206347893 title "Cry1Ac Protoxin Confers Antitumor Adjuvant Effect in a Triple-Negative Breast Cancer Mouse Model by Improving Tumor Immunity" @default.
• W4206347893 cites W1506814183 @default.
• W4206347893 cites W1589599504 @default.
• W4206347893 cites W1849585918 @default.
• W4206347893 cites W1894440327 @default.
• W4206347893 cites W1925817305 @default.
• W4206347893 cites W1953357409 @default.
• W4206347893 cites W1970160028 @default.
• W4206347893 cites W1973217224 @default.
• W4206347893 cites W1989601889 @default.
• W4206347893 cites W1994447535 @default.
• W4206347893 cites W2009780657 @default.
• W4206347893 cites W2015649564 @default.
• W4206347893 cites W2033278321 @default.
• W4206347893 cites W2040059821 @default.
• W4206347893 cites W2044224359 @default.
• W4206347893 cites W2049923037 @default.
• W4206347893 cites W2055628587 @default.
• W4206347893 cites W2055750901 @default.
• W4206347893 cites W2063386089 @default.
• W4206347893 cites W2067632426 @default.
• W4206347893 cites W2070262594 @default.
• W4206347893 cites W2075422792 @default.
• W4206347893 cites W2077668347 @default.
• W4206347893 cites W2078828659 @default.
• W4206347893 cites W2079696222 @default.
• W4206347893 cites W2079841824 @default.
• W4206347893 cites W2092448563 @default.
• W4206347893 cites W2100446496 @default.
• W4206347893 cites W2119077297 @default.
• W4206347893 cites W2121728684 @default.
• W4206347893 cites W2137158234 @default.
• W4206347893 cites W2143145234 @default.
• W4206347893 cites W2168028214 @default.
• W4206347893 cites W2211958121 @default.
• W4206347893 cites W2415527696 @default.
• W4206347893 cites W2443001171 @default.
• W4206347893 cites W2474946893 @default.
• W4206347893 cites W2510062786 @default.
• W4206347893 cites W2515667551 @default.
• W4206347893 cites W2518086154 @default.
• W4206347893 cites W2576658154 @default.
• W4206347893 cites W2588948315 @default.
• W4206347893 cites W2609283170 @default.
• W4206347893 cites W2616497407 @default.
• W4206347893 cites W2625473406 @default.
• W4206347893 cites W2648573262 @default.
• W4206347893 cites W2726959413 @default.
• W4206347893 cites W2728674371 @default.
• W4206347893 cites W2735725998 @default.
• W4206347893 cites W2762602728 @default.
• W4206347893 cites W2770078888 @default.
• W4206347893 cites W2793561245 @default.
• W4206347893 cites W2800416570 @default.
• W4206347893 cites W2807809125 @default.
• W4206347893 cites W2905353329 @default.
• W4206347893 cites W2942900492 @default.
• W4206347893 cites W2943084404 @default.
• W4206347893 cites W2964989293 @default.
• W4206347893 cites W2972296916 @default.
• W4206347893 cites W2975664695 @default.
• W4206347893 cites W2992260386 @default.
• W4206347893 cites W2997398159 @default.
• W4206347893 cites W3017095108 @default.
• W4206347893 cites W3022816445 @default.
• W4206347893 cites W3033054588 @default.
• W4206347893 cites W3137357447 @default.
• W4206347893 cites W4298417300 @default.
• W4206347893 doi "https://doi.org/10.1177/11782234211065154" @default.
• W4206347893 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35002244" @default.
• W4206347893 hasPublicationYear "2022" @default.
• W4206347893 type Work @default.
• W4206347893 citedByCount "1" @default.
• W4206347893 countsByYear W42063478932023 @default.
• W4206347893 crossrefType "journal-article" @default.
• W4206347893 hasAuthorship W4206347893A5027007571 @default.
• W4206347893 hasAuthorship W4206347893A5032831685 @default.
• W4206347893 hasAuthorship W4206347893A5049906723 @default.
• W4206347893 hasAuthorship W4206347893A5067637757 @default.
• W4206347893 hasBestOaLocation W42063478931 @default.
• W4206347893 hasConcept C102230213 @default.
• W4206347893 hasConcept C104317684 @default.
• W4206347893 hasConcept C122172344 @default.
• W4206347893 hasConcept C154317977 @default.
• W4206347893 hasConcept C202751555 @default.
• W4206347893 hasConcept C203014093 @default.
• W4206347893 hasConcept C2777863537 @default.
• W4206347893 hasConcept C2780931953 @default.
• W4206347893 hasConcept C2781151318 @default.
• W4206347893 hasConcept C502942594 @default.

• next